title: Utilizing targeted cancer therapeutic agents in combination: novel approaches and urgent requirements.
authors.affiliation: Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland 20892, USA.
authors.forename: Shivanni
authors.initials: S
authors.lastname: Kummar
authors.forename: Helen X
authors.initials: HX
authors.lastname: Chen
authors.forename: John
authors.initials: J
authors.lastname: Wright
authors.forename: Susan
authors.initials: S
authors.lastname: Holbeck
authors.forename: Myrtle Davis
authors.initials: MD
authors.lastname: Millin
authors.forename: Joseph
authors.initials: J
authors.lastname: Tomaszewski
authors.forename: James
authors.initials: J
authors.lastname: Zweibel
authors.forename: Jerry
authors.initials: J
authors.lastname: Collins
authors.forename: James H
authors.initials: JH
authors.lastname: Doroshow
mesh_terms: D000553:Ambulatory Care / Q000379:methods / Q000639:trends*; D000818:Animals; D000970:Antineoplastic Agents / Q000008:administration & dosage; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000008:administration & dosage*; D002986:Clinical Trials as Topic / Q000639:trends; D016503:Drug Delivery Systems / Q000379:methods / Q000639:trends*; D006801:Humans; D054547:National Cancer Institute (U.S.) / Q000639:trends*; D009369:Neoplasms / Q000188:drug therapy* / Q000453:epidemiology; D014481:United States / Q000453:epidemiology
chemical_list: D000970:Antineoplastic Agents